ATE222752T1
(en)
*
|
1993-10-06 |
2002-09-15 |
Amgen Inc |
STABLE PROTEIN PHOSPHOLIPID COMPOSITIONS AND METHODS
|
US5874075A
(en)
*
|
1993-10-06 |
1999-02-23 |
Amgen Inc. |
Stable protein: phospholipid compositions and methods
|
CN1055640C
(en)
*
|
1996-11-29 |
2000-08-23 |
沃维汉 |
Human calcium degrading gene concerned peptide fatty composite and preparation thereof
|
DK1014946T3
(en)
|
1997-09-18 |
2010-06-28 |
Pacira Pharmaceuticals Inc |
Delayed release liposomal anesthetic compositions
|
EP1030652B1
(en)
|
1997-11-14 |
2012-04-25 |
Pacira Pharmaceuticals, Inc. |
Production of multivesicular liposomes
|
FR2771636B1
(en)
*
|
1997-12-01 |
2001-06-15 |
Capsulis |
IMPROVED METHOD FOR AVOIDING THE DEGRADATION OF AN ACTIVE INGREDIENT
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
DE69940735D1
(en)
|
1998-07-17 |
2009-05-28 |
Pacira Pharmaceuticals Inc |
BIODEGRADABLE ARRANGEMENTS FOR THE CONTROLLED RELEASE OF INCLUDED SUBSTANCES
|
US7223406B2
(en)
|
2000-07-21 |
2007-05-29 |
The Regents Of The University Of California |
Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
|
WO2002007757A2
(en)
*
|
2000-07-21 |
2002-01-31 |
Lue Tom F |
Prevention and treatment of sexual arousal disorders
|
US20030003144A1
(en)
*
|
2001-05-01 |
2003-01-02 |
Keller Brian C. |
Sustained release formulations for nifedipine, dextromethorphan, and danazol
|
JP3742602B2
(en)
*
|
2001-05-09 |
2006-02-08 |
株式会社カネカ |
Stable solution of reduced coenzyme Q
|
US20030096000A1
(en)
*
|
2001-05-31 |
2003-05-22 |
Solis Rosa Maria |
Encapsulation of nanosuspensions in liposomes and microspheres
|
BRPI0105509B8
(en)
*
|
2001-11-05 |
2021-05-25 |
Univ Minas Gerais |
formulations of the angiotensin- (1-7) peptide using cyclodextrins, liposomes and the plga polymer
|
US20030219696A1
(en)
*
|
2002-05-23 |
2003-11-27 |
Moreland Gerald W. |
Method and apparatus for preventing backflow in dental saliva evacuators
|
RS20050300A
(en)
|
2002-10-16 |
2007-08-03 |
Euro-Celtique S.A., |
Antibodies that bind cell-associated ca 125/0772p and methods of use thereof
|
AU2003287526A1
(en)
*
|
2002-11-06 |
2004-06-03 |
|
Protein-stabilized liposomal formulations of pharmaceutical agents
|
US20050032113A1
(en)
*
|
2003-07-17 |
2005-02-10 |
Mitsubishi Pharma Corporation |
Membrane protein library for proteome analysis and method for preparing same
|
TWI262798B
(en)
*
|
2003-12-31 |
2006-10-01 |
Ind Tech Res Inst |
Liposome and drug deliver system
|
US7032632B2
(en)
*
|
2004-09-27 |
2006-04-25 |
Owens-Illinois Prescription Products Inc. |
Measuring and dispensing closure
|
CA2523032A1
(en)
|
2005-10-07 |
2007-04-07 |
Immunovaccine Technologies Inc. |
Vaccines for cancer therapy
|
US20090017108A1
(en)
*
|
2007-07-11 |
2009-01-15 |
Alexander Yuzhakov |
Liposome compositions for treatment of hepatitis C
|
CN101827613A
(en)
|
2007-09-27 |
2010-09-08 |
免疫疫苗技术有限公司 |
Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
|
US20100209452A1
(en)
*
|
2007-10-03 |
2010-08-19 |
Immunovaccine Technologies, Inc |
Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
|
EP2296696B1
(en)
*
|
2008-06-05 |
2014-08-27 |
ImmunoVaccine Technologies Inc. |
Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
|
WO2010148352A1
(en)
|
2009-06-19 |
2010-12-23 |
Altos Vision Limited |
Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
|
US10272040B2
(en)
*
|
2010-08-12 |
2019-04-30 |
Nanyang Technological University |
Liposomal formulation for ocular drug delivery
|
US20130309312A1
(en)
|
2011-01-31 |
2013-11-21 |
Maruho Co., Ltd. |
Dermal composition comprising polymeric reversed micelle, and method for producing same
|
AU2012321022B2
(en)
|
2011-10-06 |
2017-03-23 |
Immunovaccine Technologies Inc. |
Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof
|
US11278494B1
(en)
|
2021-01-22 |
2022-03-22 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11033495B1
(en)
|
2021-01-22 |
2021-06-15 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11357727B1
(en)
|
2021-01-22 |
2022-06-14 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|